The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ornitz, D. M., & Itoh, N. (2001) · Genome biology · doi:10.1186/gb-2001-2-3-reviews3005 · Cited by 2,272
Cellular signaling by fibroblast growth factor receptors
Eswarakumar, V. P., Lax, I., & Schlessinger, J. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.001 · Cited by 1,929
Receptor Specificity of the Fibroblast Growth Factor Family
Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., & Goldfarb, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15292 · Cited by 1,871
Fibroblast growth factors, their receptors and signaling
Powers, C. J., McLeskey, S. W., & Wellstein, A. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070165 · Cited by 1,332
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
Cappellen, D., De Oliveira, C., Ricol, D., de Medina, S., Bourdin, J., Sastre-Garau, X., Chopin, D., Thiery, J. P., & Radvanyi, F. (1999) · Nature Genetics · doi:10.1038/12615 · Cited by 713
Holt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K. F., Donahee, M., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 696
Chesi, M., Nardini, E., Brents, L. A., Schröck, E., Ried, T., Kuehl, W. M., & Bergsagel, P. L. (1997) · Nature Genetics · doi:10.1038/ng0797-260 · Cited by 637
Common and Distinct Elements in Cellular Signaling via EGF and FGF Receptors
Schlessinger, J. (2004) · Science · doi:10.1126/science.1105396 · Cited by 443
Th, M., van Nieuwkerk, C. M., Dingemans, K. P., Smit, J. J., Schinkel, A. H., Notenboom, R. G. E., Weerman, M. A. V. D. B., VERKRUISEN, R. P., Groen, A. K., & Elferink, R. P. J. O. (1994) · PubMed · Cited by 403
A Mouse Model of Hepatocellular Carcinoma
Nicholes, K., Guillet, S., Tomlinson, E., Hillan, K., Wright, B., Frantz, G. D., Pham, T. A., Dillard-Telm, L., Tsai, S. P., Stephan, J.-P., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61177-7 · Cited by 359
Self-citationFGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome
Xiao, S., Nalabolu, S. R., Aster, J. C., Ma, J., Abruzzo, L., Jaffe, E. S., Stone, R., Weissman, S. M., Hudson, T. J., & Fletcher, J. A. (1998) · Nature Genetics · doi:10.1038/ng0198-84 · Cited by 323
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.
Bange, J., Prechtl, D., Cheburkin, Y. V., Specht, K., Harbeck, N., Schmitt, M., Knyazeva, T., Müller, S., Gärtner, S., Sures, I., et al. (2002) · PubMed · Cited by 312
FGF-19, A NOVEL FIBROBLAST GROWTH FACTOR WITH UNIQUE SPECIFICITY FOR FGFR4
Xie, M.-H., Holcomb, I., Deuel, B., Dowd, P., Huang, A., Vagts, A., Foster, J., Liang, J., Brush, J., Gu, Q., et al. (1999) · Cytokine · doi:10.1006/cyto.1999.0485 · Cited by 301
Chesi, M., Brents, L. A., Ely, S. A., Bais, C., Robbiani, D. F., Mesri, E. A., Kuehl, W. M., & Bergsagel, P. L. (2001) · Blood · doi:10.1182/blood.v97.3.729 · Cited by 289
Jang, J., Shin, K., & Park, J.-G. (2001) · PubMed · Cited by 273
Identification of a new fibroblast growth factor receptor, FGFR5
Sleeman, M., Fraser, J., McDonald, M., Yuan, S., White, D., Grandison, P., Kumble, K., Watson, J. D., & Murison, J. G. (2001) · Gene · doi:10.1016/s0378-1119(01)00518-2 · Cited by 271
PDGF alpha- and beta-receptors activate unique and common signal transduction pathways.
Eriksson, A., Siegbahn, A., Westermark, B., Heldin, C. H., & Claesson-Welsh, L. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05085.x · Cited by 256
Richelda, R., Ronchetti, D., Baldini, L., Cro, L., Viggiano, L., Marzella, R., Rocchi, M., Otsuki, T., Lombardi, L., Maiolo, A. T., et al. (1997) · Blood · doi:10.1182/blood.v90.10.4062 · Cited by 206
Popovici, C., Zhang, B., Grégoire, M.-J., Jonveaux, P., Lafage-Pochitaloff, M., Birnbaum, D., & Pébusque, M.-J. (1999) · Blood · doi:10.1182/blood.v93.4.1381 · Cited by 201
Shimokawa, T., Furukawa, Y., Sakai, M., Li, M., Miwa, N., Lin, Y., & Nakamura, Y. (2003) · PubMed · Cited by 185
Wang, J., Stockton, D. W., & Ittmann, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0408 · Cited by 178
DORKIN, T. J., Robinson, M. C., Marsh, C., Bjartell, A., Neal, D. E., & Leung, H. Y. (1999) · Oncogene · doi:10.1038/sj.onc.1202624 · Cited by 152
Amplification of fgfr4 gene in human breast and gynecological cancers
Jaakkola, S., Salmikangas, P., Nylund, S. J., Lehtovirta, P., Nevanlinna, H. A., Partanen, J. M., Armstrong, E., & Pyrhönen, S. O. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540305 · Cited by 142
Holzmann, K., Kohlhammer, H., Schwäenen, C., Weßendorf, S., Kestler, H. A., Schwoerer, A., Rau, B., Radlwimmer, B., Döhner, H., Lichter, P., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0431 · Cited by 142
Harmer, N. J., Pellegrini, L., Chirgadze, D. Y., Fernández‐Recio, J., & Blundell, T. L. (2003) · Biochemistry · doi:10.1021/bi035320k · Cited by 131
Gowardhan, B., Douglas, D. A., Mathers, M. E., McKie, A. B., McCracken, S. R., Robson, C. N., & Leung, H. Y. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602274 · Cited by 115
Yu, C., Wang, F., Jin, C., Huang, X., & McKeehan, W. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411771200 · Cited by 114
Functional FGFR4 Gly388Arg Polymorphism Predicts Prognosis in Lung Adenocarcinoma Patients
Spinola, M., Leoni, V. P., Pignatiello, C., Conti, B., Ravagnani, F., Pastorino, U., & Dragani, T. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.17.350 · Cited by 113
Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma
Streit, S., Bange, J., Fichtner, A., Ihrler, S., Issing, W. J., & Ullrich, A. (2004) · International Journal of Cancer · doi:10.1002/ijc.20204 · Cited by 109
Zaharieva, B. M., Simon, R., Diener, P., Ackermann, D., Maurer, R. E., Alund, G., Knönagel, H., Rist, M., Wilber, K., Hering, F., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1481 · Cited by 100
Qian, Z. R., Sano, T., Asa, S. L., Yamada, S., Horiguchi, H., Tashiro, T., Li, C. C., Hirokawa, M., Kovács, K., & Ezzat, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031489 · Cited by 91
Increased expression of fibroblast growth factor 8 in human breast cancer
Marsh, S. K., Bansal, G., Zammit, C., Barnard, R. C., Coope, R. C., Roberts-Clark, D., Gomm, J. J., Coombes, R. C., & Johnston, C. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202392 · Cited by 81
FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells
Mattila, M., Ruohola, J. K., Valve, E. M., Tasanen, M. J., Seppänen, J., & Härkönen, P. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204430 · Cited by 67
Fibroblast growth factors in cancer: therapeutic possibilities
Jeffers, M., LaRochelle, W. J., & Lichenstein, H. S. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.4.469 · Cited by 66
Ruohola, J. K., Viitanen, T. P., Valve, E. M., Seppänen, J., Loponen, N., Keskitalo, J. J., Lakkakorpi, P. T., & Härkönen, P. L. (2001) · PubMed · Cited by 65
Expression of int-2 mRNA in human tumors amplified at the int-2 locus.
Liscia, D. S., Merlo, G. R., Garrett, C. T., French, D., Mariani‐Costantini, R., & Callahan, R. (1989) · PubMed · Cited by 61
Self-citationFGF-2 abnormalities in B cell chronic lymphocytic and chronic myeloid leukemias
Krejčí, P., Dvořáková, D., Krahulcová, E., Pacherník, J., Mayer, J., Hampl, A., & Dvořák, P. (2001) · Leukemia · doi:10.1038/sj.leu.2402012 · Cited by 42
Quantitative In Situ Hybridization of Tissue Microarrays
Jubb, A. M., Pham, T. Q., Frantz, G. D., Peale, F. V., Jr., & Hillan, K. J. (2006) · Humana Press eBooks · doi:10.1385/1-59745-007-3:255 · Cited by 17
Cited by
Fibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
Genetic landscape and biomarkers of hepatocellular carcinoma
Zucman-Rossi, J., Villanueva, A., Nault, J.-C., & Llovet, J. M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.061 · Cited by 1,325
FGF/FGFR signaling in health and disease
Xie, Y., Su, N., Yang, J., Tan, Q., Huang, S., Jin, M., Ni, Z., Zhang, B., Zhang, D., Luo, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00222-7 · Cited by 904
The Klotho proteins in health and disease
Kuro-o, M. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0078-3 · Cited by 707
Metadata
- Authors
- Desnoyers, L. R., Pai, R., Ferrando, R. E., Hötzel, K., Le, T., Ross, J., Carano, R., D'Souza, A., Qing, J., Mohtashemi, I., Ashkenazi, A., & French, D. M.
- Venue
- Oncogene
- Published
- 2007-06-25
- Volume
- 27
- Issue
- 1
- Pages
- 85-97
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2063746351
- Cited by
- 264
- References
- 38
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.